Pure Biologics S.A. Logo

Pure Biologics S.A.

ISIN

PLPRBLG00010

Ticker

PUR

Sector

Health Care

Sub-Industry

Biotechnology

Country

Poland

Year Founded

2010

About Pure Biologics S.A.

Company Description

Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based on our own technology platforms for the selection of active molecules – antibodies and aptamers.

Pure Biologics also offers commercial partnership options in several areas including early phase biological drug discovery and development, selection and characterization of antibodies and aptamers, as well as protein production, purification and analysis.

Served Area

Worldwide

Headquarters

Duńska 11
54-427, Wrocław
Poland

Capital Markets Information

ISIN

PLPRBLG00010

LEI

2594002TXS19AUYHIF82

Sub-Industry

Biotechnology

Listed Stock Exchange

Warsaw Stock Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.